Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAF: Liraglutide as Adjunctive Therapy to Catheter Ablation for Atrial Fibrillation
NCT03856632Phase 4Active, not recruiting
- Sponsor
- University of Miami
- Start
- Mar 2019
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in Atrial fibrillation (AFib), sponsored by University of Miami. Started Mar 2019; status: active, not recruiting.
02
Drugs
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03856632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856632.